Abstract
Retinoic acid (RA) is a potent transcriptional activator whose actions are mediated by members of the nuclear hormone receptor family. In addition to playing key roles in embryonic development and in tissue maintenance in the adult, RA is a potent anticarcinogenic agent currently in clinical use for treatment of various cancers. Here, we describe an optical method for measuring the concentrations of RA in biological samples. This method uses cellular retinoic acid-binding protein I (CRABP-I), a protein that binds RA with high affinity and specificity, as a “read-out” for its ligand. Replacing 28Leu of CRABP-I with a Cys residue allows for covalently attaching an environmentally sensitive fluorescent probe to the protein at a region that undergoes a significant conformational change upon ligand binding. Association of RA with the modified protein thus results in changes in the fluorescence of the probe, enabling reliable measurements of RA concentrations as low as 50 nM. We show that the method can be effectively used to measure RA concentrations in serum and to monitor the biosynthesis and the degradation of RA in cultured mammalian cells.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Chambon, P. (1996) A decade of molecular biology of retinoic acid receptors. FASEB. J. 10, 940–954.
Schug, T.T., Berry, D.C., Shaw, N.S., Travis, S.N., Noy, N. (2007) Opposing effects of retinoic acid on cell growth result from alternate activation of two different nuclear receptors. Cell 129, 723–733.
Noy, N. (2000) Retinoid-binding proteins: Mediators of retinoid action, Biochem. J. 348(Pt 3), 481–495.
Dong, D., Ruuska, S.E., Levinthal, D.J., Noy, N. (1999) Distinct roles for cellular retinoic acid-binding proteins I and II in regulating signaling by retinoic acid. J. Biol. Chem. 274, 23695–23698.
Budhu, A.S., Noy, N. (2002) Direct channeling of retinoic acid between cellular retinoic acid-binding protein II and retinoic acid receptor sensitizes mammary carcinoma cells to retinoic acid-induced growth arrest. Mol. Cell. Biol. 22, 2632–2641.
Boylan, J.F., Gudas, L.J. (1991) Overexpression of the cellular retinoic acid binding protein-I (CRABP-I) results in a reduction in differentiation-specific gene expression in F9 teratocarcinoma cells. J. Cell Biol. 112, 965–979.
Boylan, J.F., Gudas, L.J. (1992) The level of CRABP-I expression influences the amounts and types of all- trans-retinoic acid metabolites in F9 teratocarcinoma stem cells. J. Biol. Chem. 267, 21486–21491.
Soprano, D.R., Qin, P., Soprano, K.J. (2004) Retinoic acid receptors and cancers. Annu. Rev. Nutr. 24, 201–221.
Hong, W.K., Itri, L. (1994) Retinoids and human cancer. In: Sporn, M.B., Roberts, A.B., Goodman, D.S. (eds.), The Retinoids: Biology, Chemistry, and Medicine, Raven Press, New York, pp. 597–630.
Lotan, R. (1996) Retinoids in cancer chemoprevention. FASEB. J. 10, 1031–1039.
Yang, L.M., Tin, U.C., Wu, K., Brown, P. (1999) Role of retinoid receptors in the prevention and treatment of breast cancer. J. Mammary Gland Biol. Neoplasia. 4, 377–388.
Miller, W. H., Jr. (1998) The emerging role of retinoids and retinoic acid metabolism blocking agents in the treatment of cancer. Cancer 83, 1471–1482.
Frankel, S.R., Eardley, A., Lauwers, G., Weiss, M., Warrell, R.P., Jr. (1992) The “retinoic acid syndrome” in acute promyelocytic leukemia. Ann. Intern. Med. 117, 292–296.
De Leenheer, A.P., Lambert, W.E., Claeys, I. (1982) All-trans-retinoic acid: Measurement of reference values in human serum by high performance liquid chromatography. J. Lipid Res. 23, 1362–1367.
Kane, M.A., Folias, A.E., Wang, C., Napoli, J.L. (2008) Quantitative profiling of endogenous retinoic acid in vivo and in vitro by tandem mass spectrometry. Anal. Chem. 80, 1702–1708.
Norris, A.W., Cheng, L., Giguere, V., Rosenberger, M., Li, E. (1994) Measurement of subnanomolar retinoic acid binding affinities for cellular retinoic acid binding proteins by fluorometric titration. Biochim. Biophys. Acta 1209, 10–18.
Kleywegt, G.J., Bergfors, T., Senn, H., Le Motte, P., Gsell, B., Shudo, K., Jones, T.A. (1994) Crystal structures of cellular retinoic acid binding proteins I and II in complex with all-trans-retinoic acid and a synthetic retinoid. Structure 2, 1241–1258.
Chen, X., Tordova, M., Gilliland, G.L., Wang, L.C., Li, Y., Yan, H.G., Ji, X.H. (1998) Crystal structure of apo-cellular retinoic acid-binding protein type II (R111M) suggests a mechanism of ligand entry. J. Mol. Biol. 278, 641–653.
Mira, Y.L.R., Zheng, W.L., Kuppumbatti, Y.S., Rexer, B., Jing, Y., Ong, D.E. (2000) Retinol conversion to retinoic acid is impaired in breast cancer cell lines relative to normal cells. J. Cell Physiol. 185, 302–309.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Donato, L.J., Noy, N. (2010). Fluorescence-Based Technique for Analyzing Retinoic Acid. In: Sun, H., Travis, G. (eds) Retinoids. Methods in Molecular Biology, vol 652. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-60327-325-1_10
Download citation
DOI: https://doi.org/10.1007/978-1-60327-325-1_10
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-60327-324-4
Online ISBN: 978-1-60327-325-1
eBook Packages: Springer Protocols